Patent US6702851B1 successfully refreshed from Google Patents.
US6702851B1
Expired / Lapsed
US
⏱️ 0.0 years remaining
Prosthetic heart valve with surface modification
Assignee: Corcym SRL
•
Filing: 1998-03-18
•
Granted: 2004-03-09
•
Expires: 2018-03-18
Abstract
Abstract A biocompatible heart valve is described having incorporated therein an effective amount of applied coating to render the valve resistant to in vivo pathologic thrombus formation and resistant to in vivo pathologic calcification.
Inventors
- 👤 Joseph A. Chinn
- 👤 Jack R. Frautschi
- 👤 Richard E. Phillips
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 12:42
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/50; A61L27/507; A61L27/28; A61L27/34; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2412; A61L2400/00; A61L2400/02
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
113 words
A method for reducing calcification and thrombus formation in a biocompatible heart valve comprising a polymer selected from the group consisting of silicone rubbers, polyurethane, and polyetherurethane, said method comprising: coating, prior to implantation, said heart valve including its leaflets with a coating derived from a compound of the formula: X-Y-Z wherein X is a photochemically reactive group capable upon activation of bonding to the surface of the heart valve, Y represents nothing or a relatively inert, noninterfering skeletal moiety joining groups X and Z and is resistant to cleavage in aqueous physiological fluids, and Z is a fatty acid moiety, said coating being effective to reduce calcification and thrombus formation after implantation.
Claim 2
Independent Claim
113 words
A method for reducing calcification and thrombus formation in a biocompatible heart valve comprising a polymer selected from the group consisting of silicone rubbers, polyurethane, and polyetherurethane, said method comprising: coating, prior to implantation, said heart valve including its leaflets with a coating derived from a compound of the formula: X-Y-Z wherein X is a photochemically reactive group capable upon activation of bonding to the surface of the heart valve, Y represents nothing or a relatively inert, noninterfering skeletal moiety joining groups X and Z and is resistant to cleavage in aqueous physiological fluids, and Z is a fatty acid moiety, said coating being effective to reduce calcification and thrombus formation after implantation.
Claim 3
Dependent Claim
117 words
A biocompatible heart valve comprising: a stent defining a blood flow path; and a plurality of leaflets comprising a polymer selected from the group consisting of silicone rubber, polyurethane, and polyetherurethane, said leaflets having an applied surface coating effective to render said heart valve resistant to in vivo pathologic thrombus formation and in vivo pathologic calcification, said coating being derived from a compound of the formula X-Y-Z wherein X is a chemically reactive group capable upon activation of bonding to the surface of the heart valve; Y represents nothing or a relatively inert, noninterfering skeletal moiety joining groups X and Z and is resistant to cleavage in aqueous physiological fluids, and Z is a fatty acid moiety.
Claim 4
Dependent Claim
117 words
A biocompatible heart valve comprising: a stent defining a blood flow path; and a plurality of leaflets comprising a polymer selected from the group consisting of silicone rubber, polyurethane, and polyetherurethane, said leaflets having an applied surface coating effective to render said heart valve resistant to in vivo pathologic thrombus formation and in vivo pathologic calcification, said coating being derived from a compound of the formula X-Y-Z wherein X is a chemically reactive group capable upon activation of bonding to the surface of the heart valve; Y represents nothing or a relatively inert, noninterfering skeletal moiety joining groups X and Z and is resistant to cleavage in aqueous physiological fluids, and Z is a fatty acid moiety.
Claim 5
Independent Claim
134 words
A method for reducing calcification and thrombus formation in a biocompatible heart valve comprising a polymer selected from the group consisting of silicone rubbers, polyurethane, and polyetherurethane, said method comprising: providing a first coat, prior to implantation, to said heart valve including its leaflets, of a first coating derived from a compound of the formula: X-Y-Z wherein X is a photochemically reactive group capable upon activation of bonding to the surface of the heart valve, Y represents nothing or a relatively inert, noninterfering skeletal moiety joining groups X and Z and is resistant to cleavage in aqueous physiological fluids, and Z is a polyvinylpyrrolidone moiety, and providing a second coat, prior to implantation, to said heart valve including its leaflets, of a second coating comprising a hyaluronic acid moiety coupled to said polyvinylpyrrolidone moiety.
Claim 6
Independent Claim
134 words
A method for reducing calcification and thrombus formation in a biocompatible heart valve comprising a polymer selected from the group consisting of silicone rubbers, polyurethane, and polyetherurethane, said method comprising: providing a first coat, prior to implantation, to said heart valve including its leaflets, of a first coating derived from a compound of the formula: X-Y-Z wherein X is a photochemically reactive group capable upon activation of bonding to the surface of the heart valve, Y represents nothing or a relatively inert, noninterfering skeletal moiety joining groups X and Z and is resistant to cleavage in aqueous physiological fluids, and Z is a polyvinylpyrrolidone moiety, and providing a second coat, prior to implantation, to said heart valve including its leaflets, of a second coating comprising a hyaluronic acid moiety coupled to said polyvinylpyrrolidone moiety.
Claim 7
Dependent Claim
135 words
A biocompatible heart valve comprising: a stent defining a blood flow path; and a plurality of leaflets comprising a polymer selected from the group consisting of silicone rubber, polyurethane, and polyetherurethane, said leaflets having an applied surface coating effective to render said heart valve resistant to in vivo pathologic thrombus formation and in vivo pathologic calcification, said applied surface coating comprising: a first coating derived from a compound of the formula X-Y-Z wherein X is a chemically reactive group capable upon activation of bonding to the surface of the heart valve; Y represents nothing or a relatively inert, noninterfering skeletal moiety joining groups X and Z and is resistant to cleavage in aqueous physiological fluids, and Z is a polyvinylpyrrolidone moiety; and a second coating comprising a hyaluronic acid moiety coupled to said polyvinylpyrrolidone moiety.
Claim 8
Dependent Claim
135 words
A biocompatible heart valve comprising: a stent defining a blood flow path; and a plurality of leaflets comprising a polymer selected from the group consisting of silicone rubber, polyurethane, and polyetherurethane, said leaflets having an applied surface coating effective to render said heart valve resistant to in vivo pathologic thrombus formation and in vivo pathologic calcification, said applied surface coating comprising: a first coating derived from a compound of the formula X-Y-Z wherein X is a chemically reactive group capable upon activation of bonding to the surface of the heart valve; Y represents nothing or a relatively inert, noninterfering skeletal moiety joining groups X and Z and is resistant to cleavage in aqueous physiological fluids, and Z is a polyvinylpyrrolidone moiety; and a second coating comprising a hyaluronic acid moiety coupled to said polyvinylpyrrolidone moiety.
References Cited (Backward Citations)
US3954583A
Cited
US4363142A
Cited
US4364127A
Cited
US5002582A
Cited
US5263992A
Cited
US4979959A
Cited
US5017670A
Cited
US5098977A
Cited
US5098960A
Cited
US5019393A
Cited
US5126140A
Cited
US5167960A
Cited
US5112615A
Cited
US5509932A
Cited
US5554184A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2007-03-09 | 2007-09-08 | 2008-03-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2011-03-09 | 2011-09-08 | 2012-03-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2015-03-09 | 2015-09-08 | 2016-03-09 | $7700.00 | Window Closed / Lapsed |